GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » PS Ratio

ReNeuron Group (LSE:RENE) PS Ratio : 6.75 (As of Apr. 27, 2024)


View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ReNeuron Group's share price is £0.03375. ReNeuron Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.01. Hence, ReNeuron Group's PS Ratio for today is 6.75.

Good Sign:

ReNeuron Group PLC stock PS Ratio (=3.75) is close to 10-year low of 3.75

The historical rank and industry rank for ReNeuron Group's PS Ratio or its related term are showing as below:

LSE:RENE' s PS Ratio Range Over the Past 10 Years
Min: 3.75   Med: 1241.45   Max: 3407.89
Current: 6.75

During the past 13 years, ReNeuron Group's highest PS Ratio was 3407.89. The lowest was 3.75. And the median was 1241.45.

LSE:RENE's PS Ratio is ranked worse than
92.44% of 992 companies
in the Biotechnology industry
Industry Median: 8.85 vs LSE:RENE: 6.75

ReNeuron Group's Revenue per Sharefor the six months ended in Sep. 2023 was £0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.01.

Warning Sign:

ReNeuron Group PLC revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of ReNeuron Group was -64.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -63.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 47.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 27.60% per year.

During the past 13 years, ReNeuron Group's highest 3-Year average Revenue per Share Growth Rate was 475.90% per year. The lowest was -63.90% per year. And the median was -20.60% per year.

Back to Basics: PS Ratio


ReNeuron Group PS Ratio Historical Data

The historical data trend for ReNeuron Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group PS Ratio Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 998.03 5.05 169.29 43.57 10.06

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 43.57 - 10.06 -

Competitive Comparison of ReNeuron Group's PS Ratio

For the Biotechnology subindustry, ReNeuron Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReNeuron Group's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's PS Ratio falls into.



ReNeuron Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

ReNeuron Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.03375/0.005
=6.75

ReNeuron Group's Share Price of today is £0.03375.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ReNeuron Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


ReNeuron Group  (LSE:RENE) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


ReNeuron Group PS Ratio Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (LSE:RENE) Business Description

Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.